Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
about
Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virusBiological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaquesEfficiency comparisons of rank and permutation tests based on summary statistics computed from repeated measures data.Antiviral therapy and resistance with hepatitis B virus infection.A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.Mitochondrial toxicity and HIV therapy.Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.The organic anion transporter family: from physiology to ontogeny and the clinic.Investigational pharmacologic treatment for liver disease.Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis BChemotherapeutics and hormesis.Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.Advances in Nucleotide Antiviral Development from Scientific Discovery to Clinical Applications: Tenofovir Disoproxil Fumarate for Hepatitis B.Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.Chemical-induced nephropathy: a review of the renal tubulointerstitial lesions in humans.Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection.HIV/HBV coinfection in children and antiviral therapy.Nephrogenic hypophosphatemic osteomalacia during adefovir monotherapy for chronic hepatitis B monoinfectionAlkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.Na⁺/H⁺ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney.Medication-induced hypophosphatemia: a review.Drug safety evaluation of adefovir in HBV infection.Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901.Adefovir dipivoxil in chronic hepatitis B: history and current uses.Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition.Acquired Fanconi syndrome due to long-term adefovir administration in a patient with IgG-kappa monoclonal gammopathy and kappa Bence-Jones protein.Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.Hepatitis B virus infection in children.Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B.Editor's Highlight: Comparative Renal Safety Assessment of the Hepatitis B Drugs, Adefovir, Tenofovir, Telbivudine and Entecavir in Rats.Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report.Fanconi syndrome due to prolonged use of low-dose adefovir.Renal function of participants in the Bangkok tenofovir study--Thailand, 2005-2012.Hypophosphatemia in patients with hepatitis B virus infection undergoing long-term adefovir dipivoxil therapy.
P2860
Q28365198-7A349CAC-7B8A-49C7-AEB2-767754DFE3A4Q28775900-D015743B-A9A3-4E77-9841-979F2456D356Q30637656-2844FEC2-2EAF-425F-86E3-3517C0F54819Q33787531-39656119-83C4-4291-AECC-D4B8991B35E4Q33962669-13889885-74E4-498C-AA1D-76F895857938Q34279271-85D9A953-76C9-480E-BF4E-8DC27A1FA2CFQ34299035-C8D9C757-745E-40A4-AAE0-8CE9D9BC3FCEQ34310328-9E9D04EA-DBD7-45B4-8DC7-72921C375248Q34841865-EF42FDD9-FA8B-40B5-ACCC-3F5F32ED8BE6Q35078052-53E4EFF6-8D1A-454E-9BFF-CEECC026E775Q35155701-055B11BF-8138-450A-B752-0EAF78191B31Q35155913-93E5F656-460A-4A56-8611-2FFBCB4F05A5Q35558801-895F3EC9-2BAB-40B6-8A37-2F806E0AC38BQ35906015-17B6654F-466E-4FE3-8316-E3A59B5FF872Q35917125-A27B8368-A3C9-4E73-AC42-A2A5BFA33CCEQ35921994-5565916A-D94F-4F31-A2EF-197FCB0EFEA3Q35927205-03EA7F0F-1DC8-421B-B80A-3FBCCDB51C90Q36407276-93CBC5EF-4F9A-4840-BC0A-3BAECD12F8F3Q36775147-FD739107-4BE5-4701-ABEF-57B643368540Q36982099-1E576A24-5A15-44E1-B529-87C57868AEEDQ37401749-547BE001-B1A1-4788-8051-FE68AD2D3B91Q37593985-AC472841-CC7E-4209-A9D5-DBC1DD9A59B1Q37670314-22B9251C-D450-40EA-B3D8-18F8CD47CDE7Q37722071-B12E85D5-238B-4C2E-9783-081E8522428FQ37889298-7755B444-649C-4690-AC8B-757962D1CAEAQ37974690-4B3A5CA6-65AA-47C1-B588-03FEFB1B0466Q37975548-19B2B94D-994F-4475-8E19-B416D1458929Q38099411-45A994B7-3433-4DF3-82C3-7F3B788DE506Q38303277-E87415B5-9EDC-46A0-81A7-B059979DF08AQ38344427-36D55BC7-247C-4933-B631-6B49A45335F6Q38365905-B1F695AC-E875-451E-A3CC-11E5219C6C12Q39651695-4EDA1E66-8BD7-43A8-806C-28D94EE82957Q39652342-33AC3176-A0D4-439F-A914-C5E370130331Q40262602-3F0A7B65-103B-4A1D-A8AD-FAD93AA14D87Q40446757-E894E110-E772-42CD-90F7-CEF9F402E37FQ40541312-587C31DC-0442-4A8B-BAED-758BBA9F4C99Q41510258-0A8A33A7-CD6B-43A7-9077-3291106872DFQ41642835-4C7C85C6-5A57-4644-8FEF-53B2B63E2C58Q42218720-9FCE2208-570A-4E02-8DE0-19FBD0BB0AA0Q42269927-AF12CB48-C720-4F73-A5A4-C1887C193DBF
P2860
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Efficacy and safety of adefovi ...... a randomized controlled trial.
@en
type
label
Efficacy and safety of adefovi ...... a randomized controlled trial.
@en
prefLabel
Efficacy and safety of adefovi ...... a randomized controlled trial.
@en
P2093
P356
P1476
Efficacy and safety of adefovi ...... a randomized controlled trial.
@en
P2093
J Cherrington
P304
P356
10.1001/JAMA.282.24.2305
P407
P577
1999-12-01T00:00:00Z